Open main menu
Search Ctrl + K
Free Trial
Loading...
Halozyme Therapeutics, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.HALO
12390 El Camino Real, San Diego, CA, 92130
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Other
ARS
Scanned Paper Annual Report Submission.
15 Mar 24
UPLOAD
Letter From The Sec.
21 Jul 23
CORRESP
Correspondence With The Sec.
28 Jun 23
UPLOAD
Letter From The Sec.
14 Jun 23
ARS
Scanned Paper Annual Report Submission.
24 Mar 23
5
Annual Statement Of Changes In Beneficial Ownership Of Securities.
04 Feb 20
CT ORDER
Confidential Treatment Order By The Sec.
20 Dec 18
Prospectuses and Registrations
SC TO-T/A
Amended Tender Offer Statement By Third Party.
24 May 22
SC TO-T/A
Amended Tender Offer Statement By Third Party.
12 May 22
SC TO-T/A
Amended Tender Offer Statement By Third Party.
02 May 22
SC TO-T
Tender Offer Statement By Third Party.
26 Apr 22
SC TO-C
Written Communication Relating To A Tender Offer.
14 Apr 22
SC TO-C
Written Communication Relating To A Tender Offer.
13 Apr 22
SC TO-C
Written Communication Relating To A Tender Offer.
13 Apr 22
Ownership
SC 13G/A
12 Nov 24
SC 13G
17 Oct 24
144
Michael Labarre
16 Oct 24
4
Labarre Michael J.
16 Oct 24
144
Michael Labarre
15 Oct 24
144
Helen Torley
09 Oct 24
4
Torley Helen
09 Oct 24
Financials
10-Q
Quarterly Filing
31 Oct 24
10-Q
Quarterly Filing
06 Aug 24
10-Q
Quarterly Filing
07 May 24
10-K
Fiscal Year 2024
20 Feb 24
10-Q
Quarterly Filing
06 Nov 23
10-Q
Quarterly Filing
08 Aug 23
10-Q
Quarterly Filing
09 May 23
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
31 Oct 24
8-K
Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
26 Apr 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
20 Feb 24
8-K
Results Of Operations And Financial Condition
17 Jan 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 23
8-K
Other Events
07 Sep 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 23
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
15 Mar 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
15 Mar 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
04 Mar 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
24 Mar 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
24 Mar 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
18 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
25 Mar 22